| 10.1 |
40.2 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 7.9 |
31.4 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 7.4 |
29.7 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 5.9 |
17.6 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 5.6 |
16.7 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 4.4 |
17.7 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 4.3 |
30.2 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 3.6 |
10.7 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 3.4 |
10.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 3.3 |
13.0 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 3.2 |
9.6 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 2.9 |
28.7 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 2.8 |
8.4 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 2.7 |
8.0 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 2.6 |
7.9 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 2.6 |
38.3 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 2.4 |
7.3 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 2.4 |
7.3 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 2.4 |
7.2 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 2.3 |
9.3 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 2.2 |
8.9 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 2.1 |
27.6 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 2.1 |
24.6 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 2.0 |
14.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 2.0 |
4.0 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 2.0 |
6.0 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 1.9 |
5.8 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 1.9 |
7.8 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 1.9 |
5.7 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 1.9 |
5.6 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.8 |
9.2 |
GO:0090292 |
nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 1.8 |
7.3 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 1.8 |
23.4 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.7 |
8.4 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 1.7 |
5.0 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.6 |
8.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.6 |
20.9 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 1.6 |
30.5 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 1.6 |
12.8 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 1.6 |
7.8 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 1.6 |
4.7 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 1.6 |
6.2 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 1.5 |
7.7 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 1.5 |
12.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 1.5 |
6.1 |
GO:2000551 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 1.5 |
4.5 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 1.5 |
7.5 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 1.5 |
25.2 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 1.5 |
8.7 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.4 |
1.4 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 1.4 |
1.4 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 1.4 |
7.1 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 1.4 |
4.2 |
GO:0043379 |
memory T cell differentiation(GO:0043379) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.3 |
10.7 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.3 |
5.2 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 1.3 |
3.9 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 1.3 |
7.7 |
GO:0097090 |
presynaptic membrane organization(GO:0097090) |
| 1.3 |
3.8 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.2 |
3.6 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.2 |
8.3 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 1.2 |
10.6 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 1.2 |
8.2 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 1.2 |
5.8 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.2 |
16.2 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 1.1 |
4.5 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 1.1 |
2.3 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.1 |
3.4 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.1 |
3.4 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 1.1 |
4.5 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 1.1 |
1.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 1.1 |
4.4 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 1.1 |
4.4 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 1.1 |
5.5 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.1 |
2.2 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 1.1 |
5.4 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 1.1 |
3.2 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 1.1 |
3.2 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 1.1 |
10.7 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 1.1 |
3.2 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 1.0 |
6.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.0 |
6.2 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.0 |
2.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 1.0 |
6.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 1.0 |
3.1 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 1.0 |
3.0 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 1.0 |
3.0 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.0 |
2.0 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
| 1.0 |
2.0 |
GO:0038091 |
VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 1.0 |
3.9 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 1.0 |
1.9 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 1.0 |
2.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 1.0 |
2.9 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.9 |
2.7 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.9 |
4.5 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.9 |
26.8 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.9 |
1.8 |
GO:2000040 |
regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.9 |
8.0 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.9 |
7.1 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.9 |
3.5 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.9 |
2.6 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.9 |
4.3 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.9 |
8.6 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.9 |
11.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.8 |
34.6 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.8 |
4.2 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.8 |
8.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.8 |
1.7 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.8 |
3.3 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.8 |
5.0 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.8 |
2.5 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.8 |
4.9 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.8 |
2.4 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.8 |
1.6 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.8 |
2.4 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.8 |
3.9 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.8 |
2.4 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.8 |
2.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.8 |
1.5 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.8 |
1.5 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.8 |
8.3 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.8 |
2.3 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.8 |
1.5 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.8 |
3.0 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.7 |
1.5 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.7 |
1.5 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.7 |
2.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.7 |
6.6 |
GO:0060373 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.7 |
5.1 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.7 |
2.9 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.7 |
1.5 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.7 |
2.2 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.7 |
3.6 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.7 |
2.2 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.7 |
0.7 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.7 |
4.9 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.7 |
2.1 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.7 |
2.1 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.7 |
2.8 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.7 |
2.1 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.7 |
6.9 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.7 |
11.6 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.7 |
2.0 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.7 |
3.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.7 |
2.0 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.7 |
2.6 |
GO:1901740 |
negative regulation of myoblast fusion(GO:1901740) |
| 0.6 |
3.8 |
GO:0002591 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.6 |
5.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.6 |
1.9 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.6 |
1.9 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.6 |
1.9 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.6 |
8.8 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.6 |
8.7 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.6 |
24.7 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.6 |
9.2 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.6 |
5.5 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.6 |
5.5 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.6 |
4.9 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.6 |
6.0 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.6 |
1.8 |
GO:2000620 |
regulation of histone H4-K16 acetylation(GO:2000618) positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.6 |
4.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.6 |
0.6 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.6 |
5.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 |
4.1 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.6 |
2.4 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.6 |
9.4 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.6 |
4.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.6 |
13.2 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.6 |
6.2 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.6 |
6.7 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.6 |
3.9 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.5 |
6.0 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.5 |
4.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.5 |
1.6 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.5 |
4.3 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.5 |
3.3 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.5 |
5.4 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.5 |
2.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.5 |
3.2 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.5 |
1.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.5 |
3.7 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.5 |
3.7 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.5 |
3.7 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.5 |
2.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.5 |
11.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.5 |
2.5 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 |
3.5 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.5 |
4.0 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.5 |
1.5 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.5 |
2.0 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.5 |
3.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.5 |
2.0 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.5 |
1.0 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.5 |
1.4 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.5 |
3.3 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.5 |
4.2 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.5 |
2.8 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.5 |
1.4 |
GO:0014042 |
positive regulation of mitochondrial fusion(GO:0010636) positive regulation of neuron maturation(GO:0014042) |
| 0.5 |
1.8 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.5 |
0.9 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.4 |
2.2 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.4 |
2.7 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 |
2.6 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.4 |
6.1 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 |
14.0 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.4 |
2.2 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.4 |
1.3 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.4 |
2.6 |
GO:0086003 |
cardiac muscle cell contraction(GO:0086003) |
| 0.4 |
0.4 |
GO:1902548 |
negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.4 |
1.3 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.4 |
1.3 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.4 |
6.7 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.4 |
1.3 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.4 |
2.5 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.4 |
5.4 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.4 |
2.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
2.4 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.4 |
1.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.4 |
1.2 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.4 |
0.4 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.4 |
3.5 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.4 |
1.2 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.4 |
0.8 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.4 |
1.5 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.4 |
5.0 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.4 |
1.9 |
GO:0036508 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.4 |
5.3 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.4 |
1.9 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.4 |
2.6 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.4 |
3.0 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.4 |
0.7 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.4 |
1.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 |
1.1 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) patterning of lymph vessels(GO:0060854) |
| 0.4 |
1.1 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.4 |
1.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.4 |
1.8 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.4 |
2.2 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.4 |
2.5 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.4 |
1.4 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.4 |
0.4 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.4 |
12.6 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.4 |
1.1 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.4 |
2.8 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.4 |
0.4 |
GO:0032364 |
oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
| 0.4 |
2.8 |
GO:0045820 |
negative regulation of glycolytic process(GO:0045820) |
| 0.4 |
1.1 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.3 |
2.1 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.3 |
1.4 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.3 |
0.7 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.3 |
3.7 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.3 |
1.7 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.3 |
1.0 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
1.0 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.3 |
1.6 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.3 |
1.0 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.3 |
1.6 |
GO:0071222 |
cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
| 0.3 |
1.9 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.3 |
1.2 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.3 |
2.2 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.3 |
0.9 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.3 |
2.8 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.3 |
2.5 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.3 |
9.2 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.3 |
0.3 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.3 |
1.2 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.3 |
1.5 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.3 |
4.5 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.3 |
0.6 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.3 |
2.7 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.3 |
1.8 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
0.6 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 |
0.9 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.3 |
0.9 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 |
0.9 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 |
1.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.3 |
4.5 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.3 |
4.2 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 |
2.5 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
0.8 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.3 |
1.6 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.3 |
1.1 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.3 |
7.3 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.3 |
3.8 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.3 |
5.8 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 |
1.3 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.3 |
2.4 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.3 |
1.1 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 |
0.5 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.3 |
2.3 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.3 |
3.1 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.3 |
3.4 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.3 |
2.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 |
1.5 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 |
1.3 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.3 |
1.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
1.2 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.2 |
0.7 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.2 |
0.7 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 |
0.7 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.2 |
1.7 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.2 |
1.0 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.2 |
1.7 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.2 |
0.5 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.2 |
2.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.2 |
12.4 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.2 |
1.2 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.2 |
1.2 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 |
0.5 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.2 |
4.8 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.2 |
14.9 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.2 |
2.6 |
GO:0055119 |
relaxation of cardiac muscle(GO:0055119) |
| 0.2 |
0.7 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.2 |
2.3 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.2 |
0.7 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
1.1 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 |
3.9 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.2 |
0.5 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.2 |
0.7 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.2 |
0.7 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
0.9 |
GO:0097049 |
motor neuron apoptotic process(GO:0097049) |
| 0.2 |
2.7 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.2 |
3.1 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.2 |
1.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.7 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.2 |
0.9 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.2 |
0.4 |
GO:0048302 |
regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.2 |
2.4 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.2 |
5.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.2 |
4.3 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 |
1.1 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
4.7 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 |
3.0 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.2 |
2.8 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.2 |
0.4 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.2 |
0.4 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.2 |
4.6 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.2 |
2.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.2 |
0.8 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
1.0 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.2 |
1.8 |
GO:0031274 |
regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
2.6 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.2 |
0.4 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
1.2 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.2 |
2.9 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.2 |
1.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.2 |
0.4 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 0.2 |
3.4 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.2 |
3.0 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
3.2 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 |
1.7 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.2 |
15.9 |
GO:0007612 |
learning(GO:0007612) |
| 0.2 |
2.0 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.2 |
9.4 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.2 |
2.0 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.2 |
0.9 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
2.1 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 |
0.4 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.2 |
1.4 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.2 |
7.0 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.2 |
4.2 |
GO:0046850 |
regulation of bone remodeling(GO:0046850) |
| 0.2 |
0.5 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
5.5 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.2 |
1.5 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.2 |
1.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
0.7 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.2 |
1.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
1.7 |
GO:0060294 |
motile cilium assembly(GO:0044458) cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
9.9 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.2 |
1.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
1.1 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
0.8 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.2 |
0.3 |
GO:0045091 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.2 |
1.7 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.2 |
2.8 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.2 |
2.1 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.2 |
0.6 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 |
1.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
2.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
2.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
0.1 |
GO:0048710 |
regulation of astrocyte differentiation(GO:0048710) |
| 0.1 |
1.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
1.6 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
1.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
10.4 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
1.5 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
| 0.1 |
0.4 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
0.4 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
2.1 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
1.3 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
1.4 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.1 |
1.5 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
1.0 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
0.6 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.1 |
0.7 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.7 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
1.1 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.1 |
0.8 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.5 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 0.1 |
0.7 |
GO:0021508 |
floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.1 |
12.2 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.1 |
0.4 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.1 |
0.9 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
2.7 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
1.0 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 |
0.5 |
GO:0015871 |
choline transport(GO:0015871) negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
1.3 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
3.9 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.9 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
1.8 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.1 |
1.3 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
1.3 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 |
2.6 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
0.1 |
GO:0071035 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.1 |
1.2 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
0.9 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
1.3 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.1 |
1.4 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
2.0 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
1.1 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.2 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 |
0.3 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.4 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
2.4 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
1.0 |
GO:1902803 |
regulation of synaptic vesicle transport(GO:1902803) |
| 0.1 |
1.5 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.1 |
4.7 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.7 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.9 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 |
3.2 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.1 |
1.1 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
0.9 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
1.8 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
1.0 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
0.3 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
3.2 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 |
0.3 |
GO:1903432 |
TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
| 0.1 |
1.4 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
1.0 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
| 0.1 |
2.1 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.1 |
6.1 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
1.0 |
GO:0032402 |
establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
| 0.1 |
0.9 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 |
3.7 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
| 0.1 |
0.5 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
2.5 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.1 |
1.6 |
GO:0086001 |
cardiac muscle cell action potential(GO:0086001) |
| 0.1 |
0.3 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
1.4 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
6.7 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.1 |
2.3 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.7 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.1 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
2.2 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.8 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
3.0 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 |
0.3 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 |
1.2 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.1 |
3.4 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
1.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
3.1 |
GO:0009166 |
nucleotide catabolic process(GO:0009166) |
| 0.1 |
0.4 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
1.0 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.1 |
0.4 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
3.4 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 |
0.6 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 |
1.3 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.4 |
GO:1990564 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.7 |
GO:0045687 |
positive regulation of glial cell differentiation(GO:0045687) |
| 0.1 |
5.3 |
GO:0050817 |
coagulation(GO:0050817) |
| 0.1 |
0.3 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.5 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 |
1.2 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.8 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.1 |
0.8 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 |
1.0 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 |
0.2 |
GO:0044828 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 |
1.1 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.1 |
0.5 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
1.7 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 |
3.1 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.1 |
0.6 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
2.1 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 |
0.6 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.1 |
0.5 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
1.6 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.1 |
0.2 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.9 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
1.0 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
2.2 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.1 |
0.4 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.1 |
1.7 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.1 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) positive regulation of lipoprotein lipase activity(GO:0051006) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.4 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.1 |
0.4 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
1.0 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
1.1 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 |
0.6 |
GO:0040023 |
establishment of nucleus localization(GO:0040023) |
| 0.1 |
3.5 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.1 |
0.1 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.2 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.4 |
GO:0019377 |
glycolipid catabolic process(GO:0019377) |
| 0.1 |
1.0 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.0 |
GO:0033092 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.0 |
0.1 |
GO:0001659 |
temperature homeostasis(GO:0001659) |
| 0.0 |
0.7 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.0 |
0.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.7 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
1.6 |
GO:0051453 |
regulation of intracellular pH(GO:0051453) |
| 0.0 |
0.5 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.3 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.8 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.6 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.9 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
1.1 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 |
0.7 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
2.0 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.0 |
0.2 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 |
0.4 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
0.4 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
3.1 |
GO:0008643 |
carbohydrate transport(GO:0008643) |
| 0.0 |
0.9 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.4 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.0 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
1.2 |
GO:1901216 |
positive regulation of neuron death(GO:1901216) |
| 0.0 |
0.5 |
GO:0060444 |
branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.0 |
0.6 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.6 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
4.4 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
1.6 |
GO:0043902 |
positive regulation of multi-organism process(GO:0043902) |
| 0.0 |
0.1 |
GO:0072698 |
protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.0 |
0.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 |
0.6 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
0.1 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.0 |
1.6 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.2 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.2 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.3 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 |
0.4 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.0 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.0 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.9 |
GO:0006040 |
amino sugar metabolic process(GO:0006040) |
| 0.0 |
6.2 |
GO:0007264 |
small GTPase mediated signal transduction(GO:0007264) |
| 0.0 |
0.2 |
GO:0030307 |
positive regulation of cell growth(GO:0030307) |
| 0.0 |
0.2 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.0 |
0.6 |
GO:0031398 |
positive regulation of protein ubiquitination(GO:0031398) |
| 0.0 |
0.1 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.0 |
0.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.4 |
GO:0030042 |
actin filament depolymerization(GO:0030042) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.2 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.1 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.3 |
GO:0010976 |
positive regulation of neuron projection development(GO:0010976) |
| 0.0 |
0.3 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.2 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.2 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
